Smoking and increased severity of hepatic fibrosis in primary biliary cirrhosis: A cross validated retrospective assessment

Hepatology

Volumn 44, Issue 6, 2006, Pages 1564-1571

  Zein, Claudia O ^a,b   Beatty, Kristi ^a   Post, Anthony B ^a   Logan, Laurie ^a   Debanne, Sara ^c   McCullough, Arthur J ^d  

^a UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CIGARETTE SMOKING; COHORT ANALYSIS; DEMOGRAPHY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER FIBROSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIMARY BILIARY CIRRHOSIS; PRIORITY JOURNAL;

ALCOHOL DRINKING; COHORT STUDIES; FEMALE; HUMANS; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SMOKING;

EID: 33845600793     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.21423     Document Type: Article

References (23)

1. Newton JL, Jones DE, Metcalf JV, Park JB, Burt AD, Bassedine MF, et al. Presentation and mortality of primary biliary cirrhosis in older patients. Age Ageing 2000;29:305-309.
2. Poynard T, Mathurin P, Lai CL, Guyader D, Poupon R, Tainturier MH, et al; PANFIBROSIS Group. A comparison of fibrosis progression in chronic liver diseases. J Hepatol 2003;38:357-360.
3. Di Martino V, Lebray P, Myers RP, Pannier E, Paradise V, Charlotte F, et al. Progression of liver fibrosis in women infected with hepatitis C; long term benefit of estrogen exposure. HEPATOLOGY 2004;40:1426-1433.
4. Ong JP, Elariny H, Collantes R, Younoszai A, Chandhoke V, Reines HD, et al. Predictors of nonalcoholic steatohepatitis and advanced fibrosis in morbidly obese patients. Obes Surg 2005;15:310-315.
5. Corpechot C, Carrat F, Bonnand AM, Poupon RE, Poupon R. The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis. HEPATOLOGY 2000;32:1196-1199.
6. Howel D, Fischbacher CM, Bhopal RS, Gray J, Metcalf JV, James OF. An exploratory population based case control study of primary biliary cirrhosis. HEPATOLOGY 2000;31:1055-1060.
7. Parikh-Patel A, Gold EB, Worman HJ, Krivy KE, Gershwin MD. Risk factors for primary biliary cirrhosis in a cohort of patients from the United States. HEPATOLOGY 2001;33:16-21.
8. Gershwin ME, Selmi C, Worman HJ, Gold EB, Watnik M, Utts J, et al. Risk factors and comorbidities in primary biliary cirrhosis: A controlled interview-based study of 1032 patients and 1041 random-digit dialed matched controls from the United States. HEPATOLOGY 2005;42:1194-1202.
9. James O, Ducker S, Prince M. Case control studies support the association of environmental and genetic risk factors with primary biliary cirrhosis [Abstract 33]. HEPATOLOGY 2005;42(Suppl):209A.
10. Ala A, Stanca CM, Bu-Ghanim M, Ahmado I, Branch AD, Schiano TD, et al. Increased prevalence of primary biliary cirrhosis near Superfund toxic waste sites. HEPATOLOGY 2006;43:525-31.
11. CDC. Cigarette smoking among adults - United States, 2004. MMWR Morb Mortal Wkly Rep 2005;54:1121-1124.
12. Ludwig J, Dickson ER, McDonald GS. Staging of chronic nonsuppurative destructive cholangitis (syndrome of primary biliary cirrhosis). Virchows Arch A Pathol Anat Histol 1978;379:103-112.
13. Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. HEPATOLOGY 2001;34:121-125.
14. Hezode C, Lonjon I, Roudot-Thoraval F, Mavier JP, Pawlotsky JM, Zafrani ES, et al. Impact of Smoking of histological liver lesions in chronic hepatitis C. Gut 2003;52:126-129.
15. Dev A, Patel K, Conrad A, Blatt A, McHutchison JG. Relationship between smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2006;4:797-801.
16. Cozen W, Diaz-Sanchez D, Gauderman W, Zadnick J, Cockburn MG, Gill PS, et al. Th1 and Th2 cytokines and IgE levels in identical twins with varying levels of cigarette consumption. J Clin Immunol 2004;24:617-622.
17. Whetzel CA, Corwin EJ, Klein LC. Disruption in Th1/Th2 immune response in young adult smokers. Addict Behav 2006. In press.
18. Kaviratne M, Hesse M, Leusink M, Cheever AW, Davies SJ, McKerrow JH, et al. IL-13 activates a mechanism of tissue fibrosis that is completely TGF-beta independent. J Immunol 2004;173:4020-4029.
19. Reiman RM, Thompson RW, Feng CG, Hari D, Knight R, Cheever AW, et al. Interleukin (IL-5) augments the progression of liver fibrosis by regulating IL-13 activity. Infect Immun 2006;74:1471-1479.
20. Sugimoto R, Enjoji M, Nakamuta M, Ohta S, Kohjima M, Fukushima M, et al. Effect of IL-4 and IL-13 on collagen production in cultured L190 human hepatic stellate cells. Liver Int 2005;25:420-842.
21. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. HEPATOLOGY 1999; 30:1356-1362.
22. Houston TK, Person SD, Pletcher MJ, Liu K, Iribarren C, Kiefe CI. Active and passive smoking and development of glucose intolerance among young adults in a prospective cohort: CARDIA study. BMJ 2006;332:1064-1069.
23. Action Plan for Liver Disease Research. US Department of Health and Human Services, National Institutes of Health. December 2004. NIH Publication No. 04-5491.